Abstract |
The receptor for adeno-associated virus serotype 2 (AAV2) in Purkinje cells has not been identified, but based on work carried out in non-neuronal cell lines, heparan sulfate proteoglycan is thought to act as a primary receptor, with basic fibroblast growth factor receptor-1 being reported as a co-receptor. In this study, using antibody interference and protein competition strategies, we show specific reduction in Purkinje cell transduction by AAV2 vector in the presence of these inhibitors. We also demonstrate AAV2-mediated transgene expression in Purkinje cells in vivo that extends out to one year post-injection. These results provide new information on fibroblast growth factor receptor-1 involvement in AAV2-mediated transduction of Purkinje cells and have important implications for AAV-mediated treatment of various cerebellar disorders.
|
Authors | Lalitha R Belur, William F Kaemmerer, R Scott McIvor, Walter C Low |
Journal | Archives of virology
(Arch Virol)
Vol. 153
Issue 11
Pg. 2107-10
( 2008)
ISSN: 1432-8798 [Electronic] Austria |
PMID | 18937030
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Receptor, Fibroblast Growth Factor, Type 1
|
Topics |
- Animals
- Brain
(metabolism, virology)
- Dependovirus
(genetics, metabolism)
- Female
- Gene Expression
- Gene Transfer Techniques
- Genetic Vectors
(genetics)
- Mice
- Purkinje Cells
(metabolism, virology)
- Receptor, Fibroblast Growth Factor, Type 1
(genetics, metabolism)
- Transduction, Genetic
|